Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
Front Endocrinol (Lausanne)
; 14: 1268402, 2023.
Article
in En
| MEDLINE
| ID: mdl-37766679
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Front Endocrinol (Lausanne)
Year:
2023
Document type:
Article
Affiliation country:
Brazil